singlet oxygen has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Q; Li, D; Li, G; Li, P; Qiu, J; Shan, G | 1 |
| Bai, M; Ge, Y; Ling, X; Liu, F; Liu, Y; Su, M; Zhang, J; Zhang, S | 1 |
2 other study(ies) available for singlet oxygen and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Lysosome-targeting phenalenones as efficient type I/II photosensitizers for anticancer photodynamic therapy.
Topics: Humans; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Singlet Oxygen; Triple Negative Breast Neoplasms | 2023 |
Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer.
Topics: Acetamides; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles; Mice; Neoplasm Recurrence, Local; Phenyl Ethers; Photochemotherapy; Photosensitizing Agents; Quality of Life; Receptor, Cannabinoid, CB2; Receptors, GABA; Singlet Oxygen; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2018 |